Cytrx CEO Says Cautiously Optimistic Regarding Pending FDA Decision on Lifting Partial Clinical Hold on Trials of Cancer Drug Aldoxorubicin; Expects to Hear Back from Agency Later this Month -Reuters
Charles Gross